1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Metabolic Diseases in 2 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Xue, Z | 1 |
| Zhu, L | 1 |
| Zhou, J | 1 |
| Zhuo, L | 1 |
| Zhang, J | 1 |
| Zhang, X | 1 |
| Liu, W | 1 |
| Han, L | 1 |
| Liao, W | 1 |
| Beal, MF | 1 |
1 review available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Metabolic Diseases
| Article | Year |
|---|---|
Metabolic disorders and neurotoxicology.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Humans; Metabolic Diseases; Nerve D | 1995 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Metabolic Diseases
| Article | Year |
|---|---|
Rhynchophylline alleviates neuroinflammation and regulates metabolic disorders in a mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Metabolic Diseases; M | 2023 |